Targovax ASA (GB:0RIS) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Circio Holding ASA, a biotechnology company specializing in RNA therapeutics, has announced a significant increase in its share capital to NOK 25,184,037.00, following the conversion of convertible bonds by Atlas Special Opportunities, LLC. The company is advancing its proprietary circRNA platform and developing a cancer vaccine, TG01, which is currently undergoing clinical trials in the USA and Norway.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
